tiprankstipranks
Viracta Therapeutics, Inc. (VIRX)
:VIRX
US Market
Holding VIRX?
Track your performance easily

Viracta Therapeutics (VIRX) Financial Statements

916 Followers

Viracta Therapeutics Financial Overview

Viracta Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.103; its P/E ratio is ―; Viracta Therapeutics is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.87M$ -9.13M$ -8.28M$ -12.84M$ -11.65M
EBITDA$ -9.76M$ -8.70M$ -8.17M$ -11.13M$ -11.52M
Net Income Common Stockholders$ -10.55M$ -9.83M$ -9.14M$ -13.58M$ -12.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.13M$ 30.00M$ 39.57M$ 53.69M$ 62.95M
Total Assets$ 21.96M$ 31.32M$ 41.33M$ 56.69M$ 66.44M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 28.57M$ 28.65M$ 30.25M$ 38.37M$ 36.43M
Stockholders Equity$ -6.62M$ 2.67M$ 11.08M$ 18.32M$ 30.01M
Cash Flow-
Free Cash Flow$ -7.09M$ -9.83M$ -7.85M$ -10.03M$ -10.48M
Operating Cash Flow$ -7.09M$ -9.83M$ -7.85M$ -10.03M$ -10.54M
Investing Cash Flow$ 8.16M$ 11.70M$ 14.19M$ 9.27M$ 9.10M
Financing Cash Flow$ -1.92M$ 43.00K$ -6.60M$ 218.00K-
Currency in USD

Viracta Therapeutics Earnings and Revenue History

Viracta Therapeutics Debt to Assets

Viracta Therapeutics Cash Flow

Viracta Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis